Where is the live CopyMark page for USPTO serial 79160783?

The live record is at https://getcopymark.com/trademark/79160783. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns GREENVALLEY?

According to the public USPTO record for serial number 79160783, the listed owner(s) include: GREEN VALLEY HOLDING CO. LTD., GREEN VALLEY HOLDING CO., LTD., GREEN VALLEY HOLDING CO., LTD..

What is USPTO serial number 79160783?

Serial number 79160783 is the USPTO application identifier for the mark GREENVALLEY. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover GREENVALLEY?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: GREENVALLEY Serial# 79160783 | status 404; last event DENA | Trademark Info & Attorney Guidance

Q: What is the current status of GREENVALLEY?

GREENVALLEY (79160783) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GREENVALLEY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Howard M. Gitten

Howard M. Gitten Lewis Brisbois Bisgaard & Smith, LLP550 W. Adams Street, Suite 300Chicago, IL 60661UNITED STATES

Goods and services

Class	Description	Status	First use
005	Chinese medicine nostrum for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; medicines for human purposes for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; encapsulated pills for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; dietetic substances adapted for medical use, namely, vitamins and mineral supplements; bulk drug for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; chemico-pharmaceutical preparations for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; injectable pharmaceuticals for medical purposes for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; tablets for medical purposes for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; first aid kit; nutritional supplements; air deodorants for vehicles, household, commercial, and industrial use; medicinal herbs for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; insecticides; sanitary pads; granules being medicines for human purposes for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; injectable lyophilized powder for medical purposes for the treatment of cardiovascular disease, hypertension, Alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, and cerebral ischemia; anti-obesity medicines; blood products for medical purposes, namely, blood plasma products, red blood cell products, and leukocyte products; agricultural fungicides	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Oct 26, 2024	DENA	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED	—
Oct 26, 2024	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
May 1, 2023	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Apr 6, 2023	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Apr 6, 2023	INPC	INVALIDATION PROCESSED	—
Feb 24, 2023	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Jun 24, 2022	C71T	CANCELLED SECTION 71	—
Dec 8, 2020	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Jan 14, 2020	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 14, 2020	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Jul 8, 2016	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Apr 4, 2016	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Apr 4, 2016	FIMP	FINAL DISPOSITION PROCESSED	—
Mar 8, 2016	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Dec 8, 2015	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 20, 2015	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Sep 22, 2015	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Sep 22, 2015	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2015	GPNX	NOTIFICATION PROCESSED BY IB	—
Sep 2, 2015	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Sep 2, 2015	OP2R	NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	—
Sep 2, 2015	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
Aug 20, 2015	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Aug 13, 2015	ALIE	ASSIGNED TO LIE	—
Jul 30, 2015	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jul 20, 2015	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jul 20, 2015	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jul 20, 2015	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2015	RFNT	REFUSAL PROCESSED BY IB	—
Mar 9, 2015	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Mar 9, 2015	RFRR	REFUSAL PROCESSED BY MPU	—
Mar 6, 2015	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Mar 5, 2015	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2015	MAFR	APPLICATION FILING RECEIPT MAILED	—
Feb 27, 2015	DOCK	ASSIGNED TO EXAMINER	—
Feb 27, 2015	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Feb 26, 2015	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

GREENVALLEY